Ms Livia Stanger
University of Michigan, Ann Arbor (United States of America)
Superiority of CS585 as a selective prostacyclin receptor agonist in prevention of thrombosis
Event: ESC Congress 2023
Topic: Antiplatelet Drugs
Session: Current and novel antiplatelet therapy in cardiovascular disease
ESC 365 is supported by
